Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
29 April 2016 08:06
A new heart failure drug has gained approval
A new drug that could potentially transform the lives of people enduring heart failure has been approved.
The National Institute of Health and Care Excellence (Nice) said it has now decided to recommend the drug sacubitril valsartan for certain NHS patients.
This means that as many as 100,000 people across the country might benefit.
Tackling symptoms
Those with heart failure could potentially manage their symptoms more effectively by making use of the drug. These symptoms can include shortness of breath, as well as swelling of the feet, stomach and lower back, and fatigue.
More than half a million Britons are impacted by heart failure, with the heart muscle unable to pump enough blood that can meet the needs of the body.
Travel plans
Having a heart condition should not stop people enjoying holidays in the future.
Tailored travel insurance is available to these people, offering peace of mind when they go abroad.
Potential benefits
When it comes to the new drug, Nice said as many as 30,000 fewer hospital admissions in England could be seen thanks to its use. Deaths might also be prevented, it indicated.
Manufactured by Novartis, the sacubitril valsartan product represents the first of a new kind of drug.
It helps to widen blood vessels and increases blood flow. Blood pressure can also be reduced, removing some strain from the heart.
Professor Carole Longson, who is the director of Nice's Health Technology Evaluation Centre, said: " We are pleased to be able to recommend this innovative new treatment for those people with a severely reduced ejection fraction (when a heart is only able to pump a reduced amount of oxygenated blood around the body) and whose symptoms can mean they are almost constantly bed-bound."
The expert added: "This recommendation will help ease the symptoms of very ill people, improve their quality of life and help them to take part in normal daily activities. It should also reduce their need for hospital treatment."
21 September 2018
UK holidaymakers could be missing out on more than 60 direct flight routes thanks to Air Passenger Duty (APD), a report suggests.
[more...]
20 September 2018
Living in areas with high levels of air pollution could be linked to an increased risk of dementia, new research suggests.
19 September 2018
Multiple sclerosis (MS) patients are shelling out tens of thousands of pounds for care - and many are unable to cover the costs, a leading charity has warned.
18 September 2018
As much as £6 of every £10 spent on domestic flights in the UK goes on Air Passenger Duty (APD), new research suggests.
15 September 2018
UK driving licences might become invalid in certain European countries if the UK crashes out of the EU with no deal, the Government has warned.
14 September 2018
Online crowdfunding for cancer treatments is indirectly advancing the rise of alternative "quack" therapies, experts have warned.
13 September 2018
A "wee-stick" like those used in pregnancy testing could be employed to prevent thousands of deaths from ovarian cancer.
11 September 2018
As many as 1.3 million passengers endured severe flight delays in the last year, a new study reveals.
08 September 2018
British Airways customers are cancelling their credit cards after the carrier was hit by a 15-day data breach that compromised the details of around 380,000 people.
06 September 2018
Plastic trays at security desks harbour the highest numbers of viruses at airports, new research has discovered.
05 September 2018
Adults are being urged to take advantage of a new online tool to find out if they are at risk of having a heart attack or stroke.
04 September 2018
Child cancer patients regularly have to travel twice as far and pay out twice as much when getting treatment, new data shows.